(Q45227047)

11 December 2017

title

Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients (English)

1 reference

stem cell transplantation

11 December 2017

main subject

1 reference

1 reference

Trifilio S

1

1 reference

11 December 2017

Ortiz R

2

1 reference

11 December 2017

Pennick G

3

1 reference

11 December 2017

Verma A

4

1 reference

11 December 2017

Pi J

5

1 reference

11 December 2017

Stosor V

6

1 reference

11 December 2017

Zembower T

7

1 reference

11 December 2017

Mehta J

8

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Bone Marrow Transplantation

11 December 2017

published in

1 reference

11 December 2017

volume

35

1 reference

11 December 2017

issue

5

1 reference

11 December 2017

page(s)

509-513

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704828

11 December 2017

exact match

0 references

cites work

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Development and validation of a high-performance liquid chromatography assay for voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Adverse reactions to voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704828

21 January 2018

Identifiers

DOI

10.1038/SJ.BMT.1704828

1 reference

Dimensions Publication ID

11 December 2017

1002160645

0 references

1 reference